Andy Biggs on Drugs

Opposed rescheduling marijuana as less dangerous

Excerpts from the letter:

"Current research, science, and trends support the case that marijuana should remain a Schedule I drug. According to the National Institute on Drug Abuse (NIDA), research suggests that 30% of marijuana users have marijuana use disorder, which includes individuals who are severely addicted to the drug. It is estimated that today’s marijuana has three times the amount of THC compared to the marijuana consumed 25 years ago. A higher concentration of THC is likely linked to higher rates of addiction. These facts indicate that marijuana has a high potential for abuse and that the risk is only increasing."

Voted NO on additional Drug War funding for synthetic drugs.

GovTrack.us Summary: (SITSA): There are more than 400 known types of synthetic--or `artificial`--drugs, which mimic the effects of substances including cocaine and ecstasy. They`ve largely begun to flood the market in recent years. The bill outlaws 13 different synthetic drugs of the most pernicious varieties. There are more than 400 known types of synthetic--or `artificial`--drugs, which mimic the effects of substances including cocaine and ecstasy. They`ve largely begun to flood the market in recent years.

GovTrack Pro/Con: Supporters argue the legislation will tackle a growing scourge in a far more timely and immediate manner than what the lagging DEA is usually able to accomplish. Opponents argue the bill would too greatly expand Attorney General Jeff Sessions` ability to criminalize drugs and impose unnecessarily punitive mandatory sentences, according to a letter signed by dozens of organizations including the American Civil Liberties Union (ACLU), Human Rights Watch, and NAACP.Opponent`s argument to vote NO Rep. Jerrold Nadler (D-NY): The bill would explicitly impose mandatory minimum terms of supervised release which undermines the discretion of judges who are in the best position to make such determinations based on the facts and circumstances of each case.

Legislative outcome: House Bill Passed 239-142-46, Roll Number 268 on June 15, 2018